Using Machine Learning to Leverage Biomarker Change and Predict Colorectal Cancer Recurrence
- 1 September 2023
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 7 (7) , e2300066
Abstract
Using machine learning to leverage CEA biomarker change and predict colorectal cancer recurrence.Keywords
This publication has 27 references indexed in Scilit:
- Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health ManagementMedical Care, 2017
- Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized “CEAwatch” trialEuropean Journal of Surgical Oncology, 2015
- False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal CancerJournal of the National Comprehensive Cancer Network, 2014
- Predictors of recurrence free survival for patients with stage II and III colon cancerBMC Cancer, 2014
- A simulation model of colorectal cancer surveillance and recurrenceBMC Medical Informatics and Decision Making, 2014
- Individualized Prediction of Colon Cancer Recurrence Using a NomogramJournal of Clinical Oncology, 2008
- Super LearnerStatistical Applications in Genetics and Molecular Biology, 2007
- Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic MarkerBiometrics, 2000
- Influence of Smoking on Serum Carcinoembryonic Antigen Levels in Subjects Who Underwent Multiphasic Health Testing and ServicesJournal of Medical Systems, 1998
- Effect of Age and Cigarette Smoking on Carcinoembryonic Antigen LevelsJAMA, 1976